Physician

Adam John Defoe, M.D.

According to 2025 Medicare claims, Adam Defoe, M.D. (NPI: 1003044975) practices interventional radiology in the Fargo, ND-MN market, with the plurality of this provider's patient population coming from Cass, ND. This provider's primary affiliated billing organization is INNOVIS HEALTH LLC (NPI: 1578907655; TIN: 261175213) and primary practice location at 58103-6132. Defoe is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and Essentia Health ACO, Inc. (ACO ID: A5617), participating under the MSSP model.

Defoe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,319 traditional Medicare patients, billed 5,740 HCPCS/CPT codes, and received $330,298 in Medicare payments. The top billing code was 77067 (Screening mammography). Part D data shows 85 prescription claims across 31 beneficiaries totaling $19,762 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 21 records totaling $1,067. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $38,135 to $330,298. Similarly, Part D prescription costs have moved sharply higher in recent years, from $356 to $19,762. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$165K$330K2015 Medicare payment: $38,135 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $116,488 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $112,012 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $67,948 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $81,515 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $96,495 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $120,516 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $100,308 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $243,042 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $330,298 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015193562$38,135
20165061,517$116,488
20175121,689$112,012
20183721,008$67,948
20193791,079$81,515
20204501,307$96,495
20214891,483$120,516
20224291,215$100,308
20231,6594,028$243,042
20242,3195,740$330,298

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.9K$20K2020 Drug cost: $356 (USD; Tot_Drug_Cst)2021 Drug cost: $3,964 (USD; Tot_Drug_Cst)2022 Drug cost: $7,706 (USD; Tot_Drug_Cst)2023 Drug cost: $13,101 (USD; Tot_Drug_Cst)2024 Drug cost: $19,762 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20201933$356
20213373$3,964
20222483$7,706
20232558$13,101
20243185$19,762

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77067Screening mammography1,6651,671$90
77080Dxa bone density measurement of hip, pelvis, spine695695$29
77063Screening 3d breast mammography1,6641,670$23
G0279Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)111116$13
99152Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes184203$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
EliquisApixaban22990$17,089
Dabigatran EtexilateDabigatran Etexilate Mesylate11330$1,791
ClopidogrelClopidogrel Bisulfate453,570$787

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.21$1,067Nevro Corp.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam John Defoe, M.D.?

Tedicare shows public-source Medicare data for Adam John Defoe, M.D. (NPI 1003044975), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam John Defoe, M.D. have ACO affiliation data?

Adam John Defoe, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Essentia Health ACO, Inc. (MSSP, ACO ID A5617).

What billing organization is linked to Adam John Defoe, M.D.?

Adam John Defoe, M.D. is linked to INNOVIS HEALTH LLC (billing NPI 1578907655) in the available physician profile data.

Does Adam John Defoe, M.D. have Open Payments data?

Adam John Defoe, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.